Post by habibkhan11 on Feb 14, 2024 15:24:21 GMT 9
WINMED shows outstanding form Q1/65 with revenue of 157 million baht, profit growing 22.10%. Demand for COVID-19 products and services increases Push sales up WINMED shows 1Q22 operating results, total income of 157 million baht, net profit of 12.89 million baht, growth of 22.10%, increased demand for ATK test kits, COVID-19 RT-PCR analysis service, good response, quarterly direction. 2/65 Open country policy Support health activities to revive Moving forward with the plan to push ATK test kits and expand distribution channels. Convenience stores and Modern Trade support new product launches. Drive income in every business group to grow continuously. Mr. Nantiya Darakanon, Chief Executive Officer of Winnergy Medical Public Company Limited or WINMED, revealed that in the first quarter of 2022, the company had a total income of 157.10 million baht, an increase from the same period last year when it had income.
Total 118.96 million baht or an increase of 32.07% and a net profit of 12.89 Cambodia Telemarketing Data million baht, an increase from the same period last year with a net profit of 10.56 million baht or an increase of 22.10%. In the 1st quarter results of 2022, the company had total income. Grow as planned due to the demand for rapid COVID-19 test kit (ATK) products increasing in orders and starting to recognize revenue from the COVID-19 infection confirmation laboratory. With the RT-PCR technique, there is a good response. The number of service users continues to increase. From expanding distribution channels and adjusting marketing strategies Access to more retail customers, entrepreneurs, factories, private companies In addition, income from the original business group Starting to see a recovery People are paying more attention to health care. Especially in the women's health care product group, whose income has improved.
from an increase in the number of people receiving health check services In addition, the company receives additional dividend returns from Professional Laboratories Management Corp. Co., Ltd. (Pro -Lab), a leader in the business of providing laboratory examination and diagnosis services. in Thailand In which the company has invested in a proportion of 12.55%, Pro-Lab will recognize income from providing COVID-19 testing services in 2021 and pay out as dividends to the company in the 1st quarter of 2022. “For the business direction in the 2nd quarter of 2022, the trend is for continued growth. Supporting factors from the policy of opening the country Building confidence in using medical services The company is ready to proceed as planned. Prepare to launch new health products and services. Continuously entering the market, such as self-screening kits for cervical cancer and sexually transmitted diseases (HPV & STDs Self-Collect).
Total 118.96 million baht or an increase of 32.07% and a net profit of 12.89 Cambodia Telemarketing Data million baht, an increase from the same period last year with a net profit of 10.56 million baht or an increase of 22.10%. In the 1st quarter results of 2022, the company had total income. Grow as planned due to the demand for rapid COVID-19 test kit (ATK) products increasing in orders and starting to recognize revenue from the COVID-19 infection confirmation laboratory. With the RT-PCR technique, there is a good response. The number of service users continues to increase. From expanding distribution channels and adjusting marketing strategies Access to more retail customers, entrepreneurs, factories, private companies In addition, income from the original business group Starting to see a recovery People are paying more attention to health care. Especially in the women's health care product group, whose income has improved.
from an increase in the number of people receiving health check services In addition, the company receives additional dividend returns from Professional Laboratories Management Corp. Co., Ltd. (Pro -Lab), a leader in the business of providing laboratory examination and diagnosis services. in Thailand In which the company has invested in a proportion of 12.55%, Pro-Lab will recognize income from providing COVID-19 testing services in 2021 and pay out as dividends to the company in the 1st quarter of 2022. “For the business direction in the 2nd quarter of 2022, the trend is for continued growth. Supporting factors from the policy of opening the country Building confidence in using medical services The company is ready to proceed as planned. Prepare to launch new health products and services. Continuously entering the market, such as self-screening kits for cervical cancer and sexually transmitted diseases (HPV & STDs Self-Collect).